Cite
HARVARD Citation
Ma, A. et al. (2019). Glibenclamide treatment in a Cantú syndrome patient with a pathogenic ABCC9 gain‐of‐function variant: Initial experience. American journal of medical genetics. 179 (8), pp. 1585-1590. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ma, A. et al. (2019). Glibenclamide treatment in a Cantú syndrome patient with a pathogenic ABCC9 gain‐of‐function variant: Initial experience. American journal of medical genetics. 179 (8), pp. 1585-1590. [Online].